Trexquant Investment LP Janux Therapeutics, Inc. Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
A detailed history of Trexquant Investment LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 65,858 shares of JANX stock, worth $2.04 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
65,858Holding current value
$2.04 Million% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
229Shares Held
55.2MCall Options Held
687KPut Options Held
357K-
Ra Capital Management, L.P. Boston, MA10.4MShares$320 Million8.99% of portfolio
-
Janus Henderson Group PLC London, X03.56MShares$110 Million0.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.52MShares$109 Million7.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.06MShares$94.6 Million0.3% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$72.5 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.29B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...